2021•Oxford University Press eBooksRequires access

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

Michael Risk

Abstract

This chapter reviews a pivotal, single-armed observational study of consecutive patients with metastatic testicular germ cell tumor treated with a combination of bleomycin, vinblastine, and cisplatin. This study established that cisplatin-based combination chemotherapy resulted in a much better prognosis in patients with metastatic testicular cancer than historically observed with any other treatment and also resulted in high response rates.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Bleomycin, Vinblastine, Cisplatin, Medicine, Testicular cancer, Chemotherapy, Combination chemotherapy, Oncology